Both in Biotechnology
Hemab Therapeutics Holdings vs ADMA Biologics
Over the past year COAG returned +9.4% and ADMA returned +20.4%; their daily moves had a correlation of 0.14.
COAG +9.4% ADMA +20.4%Growth of $1, one year, split-adjusted
| Metric | COAG | ADMA |
|---|---|---|
| Price | $43.10 | $11.11 |
| Market cap | $2.01B | $2.49B |
| Today | +4.66% | +0.45% |
| 1 month | +40.9% | +9.9% |
| 6 months | — | +8.4% |
| Year to date | — | −39.1% |
| 1 year | — | −28.2% |
| Revenue growth (YoY) | — | +2.0% |
| Gross margin | — | 69.4% |
| Net margin | — | 30.4% |
| P/E (TTM) | — | 14.7× |
| Price / sales | — | 4.9× |
| Net cash | $457.5M | -$60.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 38.5% |
| Short % of float | 20.4% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).